Concepedia

Author

Martine Bourrié

Sanofi (France)

Also Known As

M Bourrie, M Bourrié, M. Bourrie, Martine Bourrie, Martine Bourrié

13

Publications

1.1K

Citations

10

H-Index

18

Concepts

All Affiliations

Sanofi (France)Inserm
MB

About

Martine Bourrié is an author at Sanofi (France) specializing in biochemistry, pharmacology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Biochemistry

3

3

178

2

Medicine

2

2

165

3

Health Sciences

1

1

83

4

Cell Biology

1

1

83

5

Hepatology

1

1

83

Martine Bourrié

×

10

Publications

1K

Citations

10

H-Index

YearCitations

Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.

Martine Bourrié, Viviane Meunier, Yves Berger,

Journal of Pharmacology and Experimental Therapeutics

1996

362

Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line

Marie‐Catherine Grès, Bernard Julian, Martine Bourrié,

Pharmaceutical Research

1998

238

Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up

Viviane Meunier, Martine Bourrié, Bernand Julian,

Xenobiotica

2000

83

Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs

Isabelle Caro, Xavier Boulenc, Monique Rousset,

International Journal of Pharmaceutics

1995

82

Role of Cytochrome P-4502C9 in Irbesartan Oxidation by Human Liver Microsomes

Martine Bourrié, Viviane Meunier, Yves Berger,

Drug Metabolism and Disposition

1999

68

Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2.

Xavier Boulenc, Martine Bourrié, Isabelle Fabre,

Journal of Pharmacology and Experimental Therapeutics

1992

67

Contribution of the N-Glucuronidation Pathway to the Overall in Vitro Metabolic Clearance of Midazolam in Humans

Sylvie Klieber, Sébastien Hugla, Robert Ngo,

Drug Metabolism and Disposition

2008

56

In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions.

Lionel Perrier, Martine Bourrié, E Marti,

Journal of Pharmacology and Experimental Therapeutics

1994

37

IN VITRO METABOLISM OF FERROQUINE (SSR97193) IN ANIMAL AND HUMAN HEPATIC MODELS AND ANTIMALARIAL ACTIVITY OF MAJOR METABOLITES ON PLASMODIUM FALCIPARUM

Wassim Daher, Lydie Pélinski, Sylvie Klieber,

Drug Metabolism and Disposition

2006

31

Effect of deuteration on the metabolism and clearance of some pharmacologically active compounds—synthesis and <i>in vitro</i> metabolism of deuterated derivatives of dronedadrone

Joseph Schofield, Denis Brasseur, Béatrice de Bruin,

Journal of Labelled Compounds and Radiopharmaceuticals

2013

13

Page 1